Bertozzi S

School of Public Health, University of California Berkeley, Berkeley, CA, USA.

2 papers · ORCID

ArticlePsychedelics

Well-being as a primary endpoint in clinical trials: a call for consensus.

Marseille E, Kettner H, Sgambati TJ +6

Europe PMC2026
ArticlePsilocybin

The economics of psychedelic-assisted therapies: A research agenda.

Marseille E, Bertozzi S, Kahn JG

Europe PMC2022